Pharma Blog Watch

A A

The Schering AG Battle Continues (In the Pipeline)
Blogger Derek Lowe discusses the continued brawl between Bayer and Merck KgaA to acquires Schering AG. According to the Financial Times, writes Lowe, "the latest figures appear to show Bayer with a slightly smaller stake in Schering than it had before, which (the paper speculates) could mean that some shareholders have withdrawn their share-tender offer to Bayer and sold them to Merck instead."